Chemical Property of 1-[4-[4-[[2-(2,4-Dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
Chemical Property:
- Vapor Pressure:1.39E-22mmHg at 25°C
- Melting Point:146℃
- Refractive Index:1.642
- Boiling Point:753.4 °C at 760 mmHg
- PKA:6.88±0.12(Predicted)
- Flash Point:409.4 °C
- PSA:69.06000
- Density:1.38 g/cm3
- LogP:4.20870
- XLogP3:4.3
- Hydrogen Bond Donor Count:0
- Hydrogen Bond Acceptor Count:6
- Rotatable Bond Count:7
- Exact Mass:530.1487608
- Heavy Atom Count:36
- Complexity:735
- Purity/Quality:
-
97% *data from raw suppliers
1-[4-[4-[[2-(2,4-DICHLOROPHENYL)-2-(IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL]METHOXY]PHENYL]PIPERAZIN-1-YL]ETHANONE 95.00% *data from reagent suppliers
Safty Information:
- Pictogram(s):
R25:;
- Hazard Codes:
T:Toxic;
- Statements:
R25:;
- Safety Statements:
S36:;
S45:;
- MSDS Files:
-
SDS file from LookChem
Useful:
- Drug Classes:Antifungal Agents
- Canonical SMILES:CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
- Recent ClinicalTrials:Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
- Recent EU Clinical Trials:A phase 2, randomized, vehicle and ketoconazole-controlled, evaluator-blinded, study to explore the efficacy, pharmacodynamics and safety of omiganan 1.75% topical gel BID in patients with mild to moderate facial seborrheic dermatitis.
- Recent NIPH Clinical Trials:The elucidation of influence and mechanisms of antifungal drugs to skin disorders caused by molecular target drugs
- Inhalation Risk:A harmful concentration of airborne particles can be reached quickly when dispersed, especially if powdered.
- Effects of Long Term Exposure:The substance may have effects on the endocrine system and liver. Animal tests show that this substance possibly causes toxicity to human reproduction or development.